Metaplastic and medullary carcinomas both have a high incidence of methylation of BRCA1 [48,49], and ~50% of breast tumors from BRCA1 mutation carriers show medullary-like features [50]. This evidence concerns the gene BRCA1 and medullary thyroid gland carcinoma.